Company Information

Company BioMerieux
www.biomerieux.com
Type:
Company
Country:
France
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
18 June 2003
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information


Communication On Progress

Published On Title Level/Status
15-Jul-2024 2024 Communication on Progress Submitted
20-Feb-2024 2023 Communication on Progress Submitted
24-Nov-2022 Communication on Progress 2021 Active
18-Nov-2021 bioMerieux Communication on Progress 2020 Active
30-Jul-2020 bioMérieux Communication on Progress 2019 Active
06-Dec-2019 Communication sur le Progrès 2018 Active
06-Dec-2019 Communication on Progress 2018 Active
04-Dec-2018 Communication on Progress Active
04-Dec-2017 Communication on Progress Active
22-Jul-2016 2015 - bioMerieux Communication on Progress Active
11-Mar-2016 bioMérieux Communication on Progress Active
10-Dec-2014 Communication on Progress Active
10-Jan-2014 2012 Communication on Progress Active
13-Jul-2012 Communication on Progress Active
17-Jun-2011 2011 Communication on Progress Learner
15-Jun-2010 2010 Communication on Progress Not applicable
07-May-2009 bioMerieux Good Practice 2007-2008 Not applicable
10-Mar-2009 Grace Period Letter Not applicable
08-Feb-2008 Actions to support and protect access to healthcare in Southeast Asia in the aftermath of the tsunami Not applicable
07-Feb-2007 Initiatives to improve research on emerging infectious pathogens and facilitate access to healthcare for all throughout the world (p.30 at link below) Not applicable
13-Jul-2005 Initiatives Undertaken to Improve Energy and Natural Resource Management at bioMérieux Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.